comparemela.com

Latest Breaking News On - Raul elizalde - Page 5 : comparemela.com

One World Universe, Inc in Negotiations With Medical Marijuana Inc Subsidiary HempMeds® to Assist With Humanitarian Efforts

One World Universe, Inc. in Negotiations With Medical Marijuana Inc. Subsidiary HempMeds® to Assist With Humanitarian Efforts One World Universe Inc. HUNTINGTON BEACH, CA, Feb. 17, 2021 (GLOBE NEWSWIRE) via NewMediaWire One World Universe Inc. (OTC: OWUV), a publicly traded company that invests in business opportunities within emerging industries and provides humanitarian efforts in over 185 countries, has announced it is in negotiations with HempMeds ®, a subsidiary of Medical Marijuana, Inc. (OTC: MJNA) which will enhance One World’s medicinal product pipeline being distributed throughout their emerging 3rd world network. Jerry C. Craig, CEO of One World, stated, “We are proud to stand with the brave pioneers, entrepreneurs and scientists who have continued to educate and advocate for CBD and marijuana as a medication and all its healing properties.  For the majority of the people who are aware and have personally experienced the vast benefits of CBD, we sta

One World Universe, Inc in Negotiations With Medical Marijuana Inc Subsidiary HempMeds® to Assist With Humanitarian Efforts

One World Universe, Inc in Negotiations With Medical Marijuana Inc Subsidiary HempMeds® to Assist With Humanitarian Efforts
einnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from einnews.com Daily Mail and Mail on Sunday newspapers.

Medical Marijuana, Inc Subsidiary HempMeds® Broadens Offerings to Include CBN and CBG as Part

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Medical Marijuana, Inc. Subsidiary HempMeds® Broadens Offerings to Include CBN and CBG as Part . Medical Marijuana, Inc.January 5, 2021 GMT Medical Marijuana, Inc. Subsidiary HempMeds® Broadens Offerings to Include CBN and CBG Medical Marijuana, Inc. Subsidiary HempMeds® Broadens Offerings to Include CBN and CBG SAN DIEGO, CA, Jan. 05, 2021 (GLOBE NEWSWIRE) via NewMediaWire Medical Marijuana, Inc.  (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds® has launched its first-ever products containing cannabigerol (CBG) and cannabinol (CBN) as part of the Company’s recently updated brand strategy.

The Week In Cannabis: Tilray-Aphria Merge, Aurora Continues Layoffs, Financings, Earnings, M&A

The Week In Cannabis: Tilray-Aphria Merge, Aurora Continues Layoffs, Financings, Earnings, M&A Benzinga 12/18/2020 Aphria (NASDAQ: APHA) and Tilray (NASDAQ: TLRY). Benzinga spoke with Aphria CEO and chairman Irwin D. Simon, who will maintain those two positions in the new company, and Tilray CEO Brendan Kennedy, who will serve in the new corporation’s board of directors. The executives shared details on how the deal came to be, and their expectations for the future, which, they say, doesn’t include massive layoffs. Cantor Fitzgerald’s analyst Pablo Zuanic praised the merger. The Canadian cannabis sector is in need of consolidation due to the oversupply problems and “historically low flower retail prices,” he explained.

Medical Marijuana, Inc Subsidiary HempMeds Announces Updated Branding Strategy to Accompany Change in Executive Leadership

Press release content from NewMediaWire. The AP news staff was not involved in its creation. Medical Marijuana, Inc. Subsidiary HempMeds Announces Updated Branding Strategy to Accompany Change in Executive Leadership Medical Marijuana, Inc.December 15, 2020 GMT San Diego, CA - ( NewMediaWire ) - December 15, 2020 -  Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds(R) has launched the rebranding of its globally recognized hemp-derived cannabidiol (CBD) products as part of its recent shift in consumer strategy and executive leadership.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.